Hetero Biopharma gets approval to make Sputnik Light Covid vaccine

Hyderabad: Pharma player Hetero announced that its biologics arm ‘Hetero Biopharma’ has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture Sputnik Light. Hetero is the first biopharmaceutical company in India to receive manufacturing and marketing (M&M) approval for the product manufactured locally for the prevention of COVID-19 in adults aged over […]

Hyderabad: Pharma player Hetero announced that its biologics arm ‘Hetero Biopharma’ has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture Sputnik Light.

Hetero is the first biopharmaceutical company in India to receive manufacturing and marketing (M&M) approval for the product manufactured locally for the prevention of COVID-19 in adults aged over 18 years, administered in a single dose. All other currently approved vaccines in India require two doses of administration.

---

Sputnik Light is the first component of Sputnik V, the world’s first registered vaccine against Covid-19. In February 2022, the Drugs Controller General of India granted emergency use permission to single-dose Sputnik Light Covid-19 vaccine in India.

“Sputnik Light has shown its neutralising activity against Omicron variant of SARS CoV-2 virus. Earlier, Sputnik V clinical trials globally had shown significant protection against Covid-19 including other subtypes,” said Dr Shubhadeep Sinha, Hetero Clinical Development and Medical Affairs Senior VP and Head, in a press release.

---

Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

---